Transient neutropenia may be a risk of treating preterm neonates with high doses of recombinant erythropoietin.
Latini
G
G
Rosati
E
E
D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced*; D011994:Recombinant Proteins; D012306:Risk
D011994:Recombinant Proteins; D004921:Erythropoietin